Long-term results of systemic thrombolysis therapy in aorto-iliac occlusive disease.

Bucek, R A; Schnürer, G; Haumer, M; Reiter, M; Ahmadi, A; Minar, E

Bucek, R A; Schnürer, G; Haumer, M; Reiter, M; Ahmadi, A; Minar, E.

Affiliation

Bucek RA; Department of Angiology, University Hospital, Vienna, Austria. robert.bucek@akh-wien.ac.at

Vasa ; 30(3): 212-8, 2001 Jul.

Article in En | MEDLINE | ID: mdl-11582952

Subject(s)

Aorta, Abdominal; Aortic Diseases/drug therapy; Arterial Occlusive Diseases/drug therapy; Iliac Artery; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator/administration & dosage; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Ischemia/drug therapy; Leg/blood supply; Male; Middle Aged; Treatment Outcome; Urokinase-Type Plasminogen Activator/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Aorta, Abdominal / Aortic Diseases / Arterial Occlusive Diseases / Urokinase-Type Plasminogen Activator / Thrombolytic Therapy / Iliac Artery Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Vasa Year: 2001 Document type: Article Affiliation country: Austria

Search on Google

Add to My VHL

XML

PubMed Links